Cost analysis of adverse events associated with non-small cell lung cancer management in France

BACKGROUND: Adverse events (AEs) related to medical treatments in non-small cell lung cancer (NSCLC) are frequent and need an appropriate costing in health economic models. Nevertheless, data on costs associated with AEs in NSCLC are scarce, particularly since the development of immunotherapy with s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chouaid, Christos, Loirat, Delphine, Clay, Emilie, Millier, Aurélie, Godard, Chloé, Fannan, Amira, Lévy-Bachelot, Laurie, Angevin, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538537/
https://www.ncbi.nlm.nih.gov/pubmed/28794648
http://dx.doi.org/10.2147/CEOR.S138963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538537/
https://www.ncbi.nlm.nih.gov/pubmed/28794648
http://dx.doi.org/10.2147/CEOR.S138963

Ejemplares similares